Gilead Sciences, Inc. (GILD)

S&P 500: 758.51
Change: 0.81%

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

Avatar louque (92.05) Submitted: 10/08/06 11:38 AM : Start Price: $32.67 GILD Score: 71.70

Gild has new products being approved by the FDA.
This company is progressing and expanding
fairly rapidly.

Featured Broker Partners